| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA6 ABL1 NACA SRCAP TRIP11 TSC22D1 CCAR1 MYOCD MED17 TAF12 MED13 MRTFA | 4.82e-06 | 303 | 156 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription factor binding | BDP1 SP1 NCOA6 SP3 NACA NR4A1 RUNX2 RUNX1 CREB1 PYHIN1 NCOR1 MYOCD TAF4 MED17 TAF12 NFAT5 LRIF1 MED13 | 2.51e-05 | 753 | 156 | 18 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA6 ABL1 NACA GON4L MED13L SRCAP TRIP11 NCOR1 TSC22D1 CCAR1 MYOCD MED17 TAF12 MED13 MRTFA | 3.58e-05 | 562 | 156 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 6.06e-05 | 2 | 156 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 7.31e-05 | 29 | 156 | 4 | GO:0035035 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.38e-04 | 34 | 156 | 4 | GO:0046966 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SP1 NCOA6 SP3 NR4A1 RUNX2 RUNX1 CREB1 NCOR1 MYOCD TAF4 MED17 TAF12 LRIF1 MED13 | 1.95e-04 | 582 | 156 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 3.50e-04 | 18 | 156 | 3 | GO:0042809 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | SP1 NCOA6 SP3 NR4A1 CREB1 NCOR1 MYOCD TAF4 MED17 LRIF1 MED13 | 4.48e-04 | 417 | 156 | 11 | GO:0061629 |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 5.97e-04 | 5 | 156 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 8.97e-04 | 55 | 156 | 4 | GO:0001046 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 9.48e-04 | 25 | 156 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 9.48e-04 | 25 | 156 | 3 | GO:0000979 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.19e-03 | 27 | 156 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.24e-03 | 7 | 156 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.32e-03 | 61 | 156 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | Hsp70 protein binding | 1.49e-03 | 63 | 156 | 4 | GO:0030544 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | SP1 SOX30 POU2F1 NR4A1 RUNX2 RUNX1 CREB1 USF3 HOXC11 EGR1 NFAT5 MYB | 1.52e-03 | 560 | 156 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 1.58e-03 | 64 | 156 | 4 | GO:0140296 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | SP1 SOX30 POU2F1 NR4A1 RUNX2 RUNX1 CREB1 USF3 HOXC11 EGR1 NFAT5 MYB | 1.67e-03 | 566 | 156 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SP1 SP3 ZBTB38 ZBTB20 ZNF180 SOX30 SREBF2 ZBTB9 POU2F1 NR4A1 RUNX2 RUNX1 RFX7 CREB1 NCOR1 USF3 HOXC11 ZFHX4 EGR1 CCAR1 NFAT5 MYB | 2.22e-03 | 1459 | 156 | 22 | GO:0000977 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ESPN TMEM67 ABL1 SPATA31A3 ANK2 SPATA31A7 TTLL5 CAMSAP3 LMTK2 CCDC187 RABGAP1 SPATA31A5 NOD2 SPATA31A1 AP1G1 TTLL4 MACF1 MRTFA | 2.38e-03 | 1099 | 156 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | protein-glutamic acid ligase activity | 2.62e-03 | 10 | 156 | 2 | GO:0070739 | |
| GeneOntologyMolecularFunction | tubulin-glutamic acid ligase activity | 2.62e-03 | 10 | 156 | 2 | GO:0070740 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 9.29e-08 | 103 | 157 | 9 | GO:2000628 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HEXB SP1 NCOA6 SP3 ZBTB38 ABL1 SOX30 NACA SREBF2 POU2F1 NR4A1 RUNX2 RUNX1 RFX7 AP3B1 CREB1 NOD2 TSC22D1 USF3 HOXC11 EGR1 PKD1 MYOCD TAF4 MED17 TAF12 NFAT5 MED13 MRTFA MYB | 1.84e-07 | 1390 | 157 | 30 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 2.29e-07 | 83 | 157 | 8 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 2.52e-07 | 84 | 157 | 8 | GO:0061614 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 3.23e-07 | 119 | 157 | 9 | GO:0010586 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 4.00e-07 | 61 | 157 | 7 | GO:1902895 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 1.38e-06 | 73 | 157 | 7 | GO:2000630 | |
| GeneOntologyBiologicalProcess | secretory granule organization | 2.17e-06 | 78 | 157 | 7 | GO:0033363 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 2.79e-06 | 197 | 157 | 10 | GO:0002244 | |
| GeneOntologyBiologicalProcess | myeloid progenitor cell differentiation | 3.05e-06 | 14 | 157 | 4 | GO:0002318 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.14e-05 | 231 | 157 | 10 | GO:0006352 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 4.67e-05 | 52 | 157 | 5 | GO:0042789 | |
| GeneOntologyBiologicalProcess | definitive hemopoiesis | 4.95e-05 | 27 | 157 | 4 | GO:0060216 | |
| GeneOntologyBiologicalProcess | proacrosomal vesicle fusion | 5.76e-05 | 2 | 157 | 2 | GO:0120211 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 7.29e-05 | 57 | 157 | 5 | GO:0009299 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | RC3H2 ABL1 PIEZO1 CD164 CAMSAP3 MDGA2 RUNX1 AP3B1 NOD2 PTPRA BRAF PTPRZ1 PKD1 TMEM131L MACF1 PLD2 NFAT5 MUC4 YTHDF2 | 8.33e-05 | 927 | 157 | 19 | GO:0030155 |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 9.16e-05 | 186 | 157 | 8 | GO:0006367 | |
| GeneOntologyBiologicalProcess | T cell differentiation | RC3H2 SP3 ABL1 RUNX2 RUNX1 AP3B1 NCOR1 BRAF EGR1 TMEM131L MYB | 1.71e-04 | 382 | 157 | 11 | GO:0030217 |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 1.95e-04 | 70 | 157 | 5 | GO:0060261 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation | 2.03e-04 | 157 | 157 | 7 | GO:0046632 | |
| GeneOntologyBiologicalProcess | melanosome organization | 2.16e-04 | 39 | 157 | 4 | GO:0032438 | |
| GeneOntologyBiologicalProcess | pigment granule organization | 2.39e-04 | 40 | 157 | 4 | GO:0048753 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 3.05e-04 | 77 | 157 | 5 | GO:2000144 | |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 3.42e-04 | 4 | 157 | 2 | GO:0072137 | |
| GeneOntologyBiologicalProcess | melanosome assembly | 3.83e-04 | 19 | 157 | 3 | GO:1903232 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 3.85e-04 | 81 | 157 | 5 | GO:0060260 | |
| GeneOntologyBiologicalProcess | hemopoiesis | SP1 NCOA6 RC3H2 SP3 PRTN3 ABL1 CD164 GON4L RUNX2 RUNX1 AP3B1 CREB1 NCOR1 TSC22D1 BRAF EGR1 PTPRZ1 TMEM131L MUC4 YTHDF2 MYB | 4.00e-04 | 1223 | 157 | 21 | GO:0030097 |
| GeneOntologyCellularComponent | transcription regulator complex | BDP1 SP1 NCOA6 SP3 POU2F1 NR4A1 RUNX2 RUNX1 CREB1 NCOR1 MYOCD TAF4 MED17 TAF12 NFAT5 MYB | 1.22e-05 | 596 | 158 | 16 | GO:0005667 |
| MousePheno | pericardial effusion | 6.00e-07 | 111 | 124 | 9 | MP:0005312 | |
| MousePheno | effusion | 8.21e-06 | 152 | 124 | 9 | MP:0021205 | |
| MousePheno | increased nucleated erythrocyte cell number | 5.77e-05 | 47 | 124 | 5 | MP:0009395 | |
| MousePheno | abnormal nucleated erythrocyte cell number | 7.07e-05 | 49 | 124 | 5 | MP:0012397 | |
| Domain | TMEM131-like | 6.49e-05 | 2 | 151 | 2 | IPR022113 | |
| Domain | Med13_N | 6.49e-05 | 2 | 151 | 2 | PF11597 | |
| Domain | Mediator_Med13_N_met/fun | 6.49e-05 | 2 | 151 | 2 | IPR021643 | |
| Domain | TMEM131_like | 6.49e-05 | 2 | 151 | 2 | PF12371 | |
| Domain | Med13_C | 6.49e-05 | 2 | 151 | 2 | PF06333 | |
| Domain | Mediator_Med13 | 6.49e-05 | 2 | 151 | 2 | IPR009401 | |
| Domain | DUF4599 | 1.08e-04 | 12 | 151 | 3 | PF15371 | |
| Domain | DUF4599 | 1.08e-04 | 12 | 151 | 3 | IPR027970 | |
| Domain | Runt | 1.94e-04 | 3 | 151 | 2 | PF00853 | |
| Domain | RUNT | 1.94e-04 | 3 | 151 | 2 | PS51062 | |
| Domain | TF_Runt-rel_RUNX | 1.94e-04 | 3 | 151 | 2 | IPR016554 | |
| Domain | RunxI | 1.94e-04 | 3 | 151 | 2 | PF08504 | |
| Domain | Runt_dom | 1.94e-04 | 3 | 151 | 2 | IPR013524 | |
| Domain | RunxI_C_dom | 1.94e-04 | 3 | 151 | 2 | IPR013711 | |
| Domain | Runx_central_dom | 1.94e-04 | 3 | 151 | 2 | IPR027384 | |
| Domain | - | 1.94e-04 | 3 | 151 | 2 | 4.10.770.10 | |
| Domain | AML1_Runt | 1.94e-04 | 3 | 151 | 2 | IPR000040 | |
| Domain | Clathrin/coatomer_adapt-like_N | 2.19e-04 | 15 | 151 | 3 | IPR002553 | |
| Domain | Adaptin_N | 2.19e-04 | 15 | 151 | 3 | PF01602 | |
| Domain | MYB_LIKE | 2.45e-04 | 38 | 151 | 4 | PS50090 | |
| Domain | Gal_mutarotase_N | 3.85e-04 | 4 | 151 | 2 | IPR031727 | |
| Domain | B2-adapt-app_C | 3.85e-04 | 4 | 151 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 3.85e-04 | 4 | 151 | 2 | IPR015151 | |
| Domain | NtCtMGAM_N | 3.85e-04 | 4 | 151 | 2 | PF16863 | |
| Domain | - | 6.19e-04 | 21 | 151 | 3 | 1.10.720.30 | |
| Domain | NIDO_dom | 6.39e-04 | 5 | 151 | 2 | IPR003886 | |
| Domain | AP_beta | 6.39e-04 | 5 | 151 | 2 | IPR026739 | |
| Domain | NIDO | 6.39e-04 | 5 | 151 | 2 | SM00539 | |
| Domain | NIDO | 6.39e-04 | 5 | 151 | 2 | PF06119 | |
| Domain | NIDO | 6.39e-04 | 5 | 151 | 2 | PS51220 | |
| Domain | SANT | 7.08e-04 | 50 | 151 | 4 | SM00717 | |
| Domain | SAP | 7.13e-04 | 22 | 151 | 3 | PF02037 | |
| Domain | SAP | 8.15e-04 | 23 | 151 | 3 | SM00513 | |
| Domain | SANT/Myb | 8.22e-04 | 52 | 151 | 4 | IPR001005 | |
| Domain | p53/RUNT-type_TF_DNA-bd | 9.53e-04 | 6 | 151 | 2 | IPR012346 | |
| Domain | - | 9.53e-04 | 6 | 151 | 2 | 2.60.40.720 | |
| Domain | Glyco_hydro_31_AS | 9.53e-04 | 6 | 151 | 2 | IPR030458 | |
| Domain | PKD/REJ-like | 9.53e-04 | 6 | 151 | 2 | IPR002859 | |
| Domain | REJ | 9.53e-04 | 6 | 151 | 2 | PF02010 | |
| Domain | SAP | 1.05e-03 | 25 | 151 | 3 | PS50800 | |
| Domain | SAP_dom | 1.05e-03 | 25 | 151 | 3 | IPR003034 | |
| Domain | Glyco_hydro_31 | 1.33e-03 | 7 | 151 | 2 | IPR000322 | |
| Domain | RPEL | 1.33e-03 | 7 | 151 | 2 | PS51073 | |
| Domain | RPEL | 1.33e-03 | 7 | 151 | 2 | SM00707 | |
| Domain | Glyco_hydro_31 | 1.33e-03 | 7 | 151 | 2 | PF01055 | |
| Domain | RPEL | 1.33e-03 | 7 | 151 | 2 | PF02755 | |
| Domain | RPEL_repeat | 1.33e-03 | 7 | 151 | 2 | IPR004018 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.33e-03 | 7 | 151 | 2 | PS00129 | |
| Domain | Homeodomain-like | 1.54e-03 | 332 | 151 | 9 | IPR009057 | |
| Domain | Trefoil | 1.76e-03 | 8 | 151 | 2 | PF00088 | |
| Domain | - | 2.16e-03 | 283 | 151 | 8 | 1.10.10.60 | |
| Domain | Alpha_adaptinC2 | 2.25e-03 | 9 | 151 | 2 | PF02883 | |
| Domain | P_TREFOIL_2 | 2.25e-03 | 9 | 151 | 2 | PS51448 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.25e-03 | 9 | 151 | 2 | IPR008152 | |
| Domain | PKD/Chitinase_dom | 2.25e-03 | 9 | 151 | 2 | IPR022409 | |
| Domain | Alpha_adaptinC2 | 2.25e-03 | 9 | 151 | 2 | SM00809 | |
| Domain | PKD | 2.25e-03 | 9 | 151 | 2 | SM00089 | |
| Domain | PD | 2.25e-03 | 9 | 151 | 2 | SM00018 | |
| Domain | Sp1_fam | 2.80e-03 | 10 | 151 | 2 | IPR030450 | |
| Domain | IGc2 | 3.05e-03 | 235 | 151 | 7 | SM00408 | |
| Domain | Ig_sub2 | 3.05e-03 | 235 | 151 | 7 | IPR003598 | |
| Domain | - | 3.40e-03 | 11 | 151 | 2 | 4.10.110.10 | |
| Domain | PKD | 3.40e-03 | 11 | 151 | 2 | PS50093 | |
| Domain | PKD_dom | 3.40e-03 | 11 | 151 | 2 | IPR000601 | |
| Domain | - | 3.40e-03 | 11 | 151 | 2 | 2.60.40.670 | |
| Domain | P_trefoil_dom | 4.06e-03 | 12 | 151 | 2 | IPR000519 | |
| Domain | Coatomer/clathrin_app_Ig-like | 4.06e-03 | 12 | 151 | 2 | IPR013041 | |
| Domain | TTL | 4.78e-03 | 13 | 151 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 4.78e-03 | 13 | 151 | 2 | IPR004344 | |
| Domain | TTL | 4.78e-03 | 13 | 151 | 2 | PF03133 | |
| Domain | SEA | 5.54e-03 | 14 | 151 | 2 | SM00200 | |
| Domain | - | 6.36e-03 | 15 | 151 | 2 | 3.30.70.960 | |
| Domain | VWF_type-D | 7.23e-03 | 16 | 151 | 2 | IPR001846 | |
| Domain | VWFD | 7.23e-03 | 16 | 151 | 2 | PS51233 | |
| Domain | VWD | 7.23e-03 | 16 | 151 | 2 | SM00216 | |
| Domain | VWD | 7.23e-03 | 16 | 151 | 2 | PF00094 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 3.55e-05 | 118 | 109 | 7 | M27316 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 4.04e-05 | 82 | 109 | 6 | M2 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 4.64e-05 | 84 | 109 | 6 | M1008 | |
| Pathway | REACTOME_ADIPOGENESIS | 2.08e-04 | 110 | 109 | 6 | M48259 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.34e-04 | 16 | 109 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.83e-04 | 17 | 109 | 3 | M27412 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.83e-04 | 17 | 109 | 3 | M47514 | |
| Pathway | WP_ESTROGEN_SIGNALING | 3.20e-04 | 77 | 109 | 5 | MM15934 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.37e-04 | 18 | 109 | 3 | M47516 | |
| Pathway | KEGG_LYSOSOME | 3.48e-04 | 121 | 109 | 6 | M11266 | |
| Pathway | WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING | 3.98e-04 | 19 | 109 | 3 | M39358 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 4.30e-04 | 46 | 109 | 4 | MM15949 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 4.66e-04 | 20 | 109 | 3 | M47517 | |
| Pathway | REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS | 5.40e-04 | 21 | 109 | 3 | M12347 | |
| Pathway | WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE | 5.83e-04 | 5 | 109 | 2 | M45554 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SP1 RC3H2 SP3 ZBTB38 CENPT ZNF180 SOX30 SREBF2 GON4L POU2F1 NR4A1 RUNX2 RUNX1 RFX7 CREB1 TSC22D1 USF3 HOXC11 ZFHX4 EGR1 DBX1 NFAT5 MYB | 3.19e-11 | 908 | 159 | 23 | 19274049 |
| Pubmed | 6.26e-09 | 6 | 159 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 6.26e-09 | 6 | 159 | 4 | 25930072 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 PDE4A B4GALNT4 ABL1 PIEZO1 RTTN KIAA0319L LMTK2 PFAS REV3L MED13L SRCAP LYST NOD2 NCOR1 TTLL4 PKD1 UBE3C BCAM MBD5 GCN1 MED13 | 7.58e-09 | 1105 | 159 | 22 | 35748872 |
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 2.07e-08 | 19 | 159 | 5 | 16799563 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | SP3 SREBF2 RUNX2 RUNX1 ATAD2 CREB1 HOXC11 ZFHX4 NFAT5 YTHDF2 MED13 GNL3 | 3.31e-08 | 321 | 159 | 12 | 32098917 |
| Pubmed | DPH1 SP1 SP3 ABCB7 SREBF2 POU2F1 PFAS MED13L ATAD2 CREB1 SLC38A2 ZNF106 UBE2R2 GTPBP2 PTPRA DBX1 NPAP1 TMEM131L ALG3 TAF4 GCN1 YTHDF2 MED13 | 4.30e-08 | 1327 | 159 | 23 | 32694731 | |
| Pubmed | Regulation of GATA-3 expression during CD4 lineage differentiation. | 8.65e-08 | 10 | 159 | 4 | 21357543 | |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 19306294 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 15523672 | ||
| Pubmed | RC3H2 RPN2 NACA CAMSAP3 SREBF2 GON4L PFAS AP3B1 GTPBP2 DNAJC10 AP1B1 AP1G1 CCAR1 YTHDF2 MGRN1 | 3.44e-07 | 650 | 159 | 15 | 38777146 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 18604866 | ||
| Pubmed | SP1 SREBF2 CREB1 ZNF106 TSC22D1 USF3 POM121 BRAF EGR1 MACF1 BICRAL MBD5 GCN1 | 4.18e-07 | 486 | 159 | 13 | 20936779 | |
| Pubmed | TAPT1 MBOAT7 KIAA0319L SREBF2 RABGAP1 TRIP11 LYST DMXL1 SLC38A2 SLC7A2 GORASP2 TMEM131L TMEM131 | 6.29e-07 | 504 | 159 | 13 | 34432599 | |
| Pubmed | SP1 NCOA6 RPN2 NACA ZBTB9 GON4L POU2F1 SRCAP RFX7 CREB1 NCOR1 HOXC11 ZFHX4 CCAR1 TAF4 MED17 TAF12 SAP130 LRIF1 YTHDF2 GNL3 MYB | 6.50e-07 | 1429 | 159 | 22 | 35140242 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HEXB TMEM67 FAT4 ABCB7 MBOAT7 RPN2 PIEZO1 KIAA0319L RABGAP1 DMXL1 IGSF10 SLC38A2 NPTN GORASP2 DNAJC10 NUP210 TMEM131L TMEM131 ALG3 MGRN1 | 6.62e-07 | 1201 | 159 | 20 | 35696571 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP1 NCOA6 SP3 ZNF804A NCOR1 USF3 POM121 EGR1 SAP130 PRRC1 MRTFA MGRN1 | 7.60e-07 | 430 | 159 | 12 | 35044719 |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 14979875 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 12560508 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 16061936 | ||
| Pubmed | ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1. | 9.31e-07 | 5 | 159 | 3 | 12771217 | |
| Pubmed | SP1 SP3 ZBTB20 ZNF180 POU2F1 RUNX2 SRCAP ATAD2 NCOR1 TSC22D1 EGR1 CCAR1 TAF12 NFAT5 MRTFA MYB | 1.04e-06 | 808 | 159 | 16 | 20412781 | |
| Pubmed | Activation of mouse RAG-2 promoter by Myc-associated zinc finger protein. | 1.86e-06 | 6 | 159 | 3 | 15094381 | |
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 16491076 | ||
| Pubmed | STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. | 1.92e-06 | 20 | 159 | 4 | 17967894 | |
| Pubmed | 3.10e-06 | 257 | 159 | 9 | 30945288 | ||
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 15817708 | ||
| Pubmed | NCOA6 ZBTB9 POU2F1 RUNX2 MED13L RUNX1 CREB1 NCOR1 AP1B1 EGR1 CCAR1 BICRAL TAF4 MED17 C2orf49 SAP130 LRIF1 MYB | 3.31e-06 | 1103 | 159 | 18 | 34189442 | |
| Pubmed | 4.16e-06 | 24 | 159 | 4 | 32212159 | ||
| Pubmed | 5.16e-06 | 8 | 159 | 3 | 11926829 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP1 NCOA6 ZBTB20 RPN2 NR4A1 RUNX1 SRCAP RFX7 CREB1 NCOR1 ZNF106 HOXC11 CCAR1 TAF4 MED17 TAF12 SAP130 LRIF1 GNL3 | 7.89e-06 | 1294 | 159 | 19 | 30804502 |
| Pubmed | SP1 NCOA6 FAT4 MBOAT7 MUC16 REV3L AP3B1 TRIP11 TMEM200A SLC38A2 NCOR1 AP1B1 MED17 | 8.24e-06 | 638 | 159 | 13 | 31182584 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | SP1 SP3 ZBTB20 SOX30 SREBF2 NR4A1 RUNX2 RFX7 CREB1 HOXC11 EGR1 NFAT5 | 8.45e-06 | 544 | 159 | 12 | 28473536 |
| Pubmed | ABCB7 SREBF2 LMTK2 SRCAP AP3B1 CDCP1 SLC38A2 UBE2R2 BRAF AP1G1 TTLL4 TMEM131L MACF1 TMEM131 NFAT5 MRTFA TMEM18 | 1.06e-05 | 1084 | 159 | 17 | 11544199 | |
| Pubmed | 1.11e-05 | 164 | 159 | 7 | 32409323 | ||
| Pubmed | Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. | 2.00e-05 | 12 | 159 | 3 | 1989904 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8668525 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 10825178 | ||
| Pubmed | HPV8 activates cellular gene expression mainly through Sp1/3 binding sites. | 2.08e-05 | 2 | 159 | 2 | 31299490 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 9233771 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24315104 | ||
| Pubmed | Polyglutamylation is a post-translational modification with a broad range of substrates. | 2.08e-05 | 2 | 159 | 2 | 18045879 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 18321855 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 29562502 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 25538045 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24616094 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 21622556 | ||
| Pubmed | Glucocorticoids delay RAF-induced senescence promoted by EGR1. | 2.08e-05 | 2 | 159 | 2 | 31371485 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 3035575 | ||
| Pubmed | Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8). | 2.08e-05 | 2 | 159 | 2 | 3498943 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 20585028 | ||
| Pubmed | Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors. | 2.08e-05 | 2 | 159 | 2 | 31164147 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 1534146 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 31852446 | ||
| Pubmed | Interaction between intrinsically disordered regions in transcription factors Sp1 and TAF4. | 2.08e-05 | 2 | 159 | 2 | 27515574 | |
| Pubmed | Expression of the Pkd1 gene is momentously regulated by Sp1. | 2.08e-05 | 2 | 159 | 2 | 17890878 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 17681019 | ||
| Pubmed | Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice. | 2.08e-05 | 2 | 159 | 2 | 37735515 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 26807725 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24594598 | ||
| Pubmed | Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain. | 2.08e-05 | 2 | 159 | 2 | 7889415 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 29730354 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 3025647 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15951564 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 33212816 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 2452747 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 9233619 | ||
| Pubmed | Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. | 2.08e-05 | 2 | 159 | 2 | 22464952 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 10594036 | ||
| Pubmed | Stalk region of beta-chain enhances the coreceptor function of CD8. | 2.08e-05 | 2 | 159 | 2 | 12847256 | |
| Pubmed | Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. | 2.08e-05 | 2 | 159 | 2 | 8845379 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 20564193 | ||
| Pubmed | Transcriptional diversity at the duplicated human CD8 beta loci. | 2.08e-05 | 2 | 159 | 2 | 8436166 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 23544943 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8654374 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 21248046 | ||
| Pubmed | Fluid shear stress induces Runx-2 expression via upregulation of PIEZO1 in MC3T3-E1 cells. | 2.08e-05 | 2 | 159 | 2 | 32181967 | |
| Pubmed | A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. | 2.08e-05 | 2 | 159 | 2 | 29316427 | |
| Pubmed | Sp1 and Sp3 activate transcription of the human dopamine transporter gene. | 2.08e-05 | 2 | 159 | 2 | 15816870 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 3169881 | ||
| Pubmed | Sp family transcription factors regulate expression of rat D2 dopamine receptor gene. | 2.08e-05 | 2 | 159 | 2 | 9628590 | |
| Pubmed | The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat cells. | 2.08e-05 | 2 | 159 | 2 | 14608051 | |
| Pubmed | Esr, a second locus in the house mouse controlling esterase-5. | 2.08e-05 | 2 | 159 | 2 | 7103930 | |
| Pubmed | Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. | 2.08e-05 | 2 | 159 | 2 | 16059634 | |
| Pubmed | Differentiation-dependent and cell-specific regulation of the hIGFBP-1 gene in human endometrium. | 2.08e-05 | 2 | 159 | 2 | 9329821 | |
| Pubmed | Nuclear pore complex assembly and maintenance in POM121- and gp210-deficient cells. | 2.08e-05 | 2 | 159 | 2 | 16702234 | |
| Pubmed | Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. | 2.08e-05 | 2 | 159 | 2 | 5558567 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 32180230 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 29325037 | ||
| Pubmed | T-cell receptor signaling induces proximal Runx1 transactivation via a calcineurin-NFAT pathway. | 2.08e-05 | 2 | 159 | 2 | 24310293 | |
| Pubmed | O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. | 2.08e-05 | 2 | 159 | 2 | 19070619 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 12034498 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 17290219 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 31928221 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 14766015 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 12237304 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 27693509 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15798204 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 28857320 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 14970199 | ||
| Interaction | NR3C1 interactions | SP1 NCOA6 FAT4 ZBTB20 MBOAT7 RPN2 ZBTB9 MUC16 POU2F1 REV3L NR4A1 AP3B1 CREB1 TRIP11 TMEM200A SLC38A2 NCOR1 AP1B1 EGR1 NUP210 BCAM MED17 LRIF1 | 9.97e-07 | 974 | 151 | 23 | int:NR3C1 |
| Interaction | FHL2 interactions | SP1 SP3 SOX30 SREBF2 RUNX2 RUNX1 CREB1 NCOR1 ZNF106 CCAR1 NFAT5 SAP130 LRIF1 MRTFA | 1.75e-06 | 396 | 151 | 14 | int:FHL2 |
| Interaction | ZBTB7B interactions | SP1 SP3 SREBF2 RUNX2 RUNX1 ATAD2 CREB1 HOXC11 ZFHX4 NFAT5 YTHDF2 MED13 GNL3 | 3.97e-06 | 366 | 151 | 13 | int:ZBTB7B |
| Interaction | TBP interactions | 2.17e-05 | 253 | 151 | 10 | int:TBP | |
| Interaction | HIF1A interactions | SP1 NR4A1 RUNX2 MED13L RUNX1 CREB1 NUP210 PLD2 UBE3C CDC34 GCN1 MED13 GNL3 | 2.87e-05 | 441 | 151 | 13 | int:HIF1A |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.79e-04 | 53 | 96 | 4 | 532 | |
| GeneFamily | CD molecules|Mucins | 1.80e-04 | 21 | 96 | 3 | 648 | |
| GeneFamily | Cyclins|Mediator complex | 7.05e-04 | 33 | 96 | 3 | 1061 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 9.80e-04 | 9 | 96 | 2 | 755 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.68e-03 | 161 | 96 | 5 | 593 | |
| GeneFamily | Tubulin tyrosine ligase family | 2.44e-03 | 14 | 96 | 2 | 779 | |
| GeneFamily | Cadherin related | 3.60e-03 | 17 | 96 | 2 | 24 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.47e-06 | 180 | 157 | 9 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 ZBTB20 MAMLD1 RABGAP1 REV3L MED13L RUNX1 AP3B1 CREB1 ZNF804A PTPRA TMEM131L MACF1 TMEM131 BICRAL TAF4 MED13 MRTFA | 4.04e-06 | 856 | 157 | 18 | M4500 |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 2.69e-05 | 198 | 157 | 8 | M6123 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 2.89e-05 | 200 | 157 | 8 | M4512 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN | 2.89e-05 | 200 | 157 | 8 | M8297 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 NCOA6 ZBTB38 ZNF180 TTLL5 GON4L POU2F1 RABGAP1 REV3L AP3B1 UBE2R2 USF3 CCAR1 TMEM131L MACF1 MBD5 TAF12 C2orf49 | 1.25e-05 | 780 | 152 | 18 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | BDP1 ZBTB20 CENPT PRR36 CAMSAP3 MAMLD1 POU2F1 REV3L RUNX2 AP3B1 ZFHX4 EGR1 CCAR1 MACF1 TMEM131 BCAM MED17 TSACC MUC4 LRIF1 | 2.69e-05 | 989 | 152 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 NCOA6 ZBTB38 ZBTB20 ZNF180 MAMLD1 GON4L MDGA2 AP3B1 NCOR1 UBE2R2 PTPRZ1 NUP210 CCAR1 TMEM131L TAF12 C2orf49 MRTFA | 2.89e-05 | 831 | 152 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | SP3 FAT4 PIEZO1 CAMSAP3 MUC16 REV3L MED13L RUNX1 AP3B1 MEX3C SLC38A2 SLC7A2 TSC22D1 ZFHX4 TMEM131L NFAT5 MRTFA | 5.37e-05 | 791 | 152 | 17 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-08 | 176 | 158 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.52e-08 | 188 | 158 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 195 | 158 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.48e-07 | 135 | 158 | 7 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.76e-07 | 136 | 158 | 7 | a43b3db1754c619d328a26a2ba6af4756629a723 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.19e-06 | 166 | 158 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-06 | 173 | 158 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-06 | 173 | 158 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-06 | 173 | 158 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 184 | 158 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 186 | 158 | 7 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.64e-06 | 186 | 158 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-06 | 190 | 158 | 7 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-06 | 192 | 158 | 7 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 193 | 158 | 7 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 193 | 158 | 7 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 193 | 158 | 7 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 193 | 158 | 7 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 195 | 158 | 7 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-06 | 196 | 158 | 7 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-06 | 196 | 158 | 7 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.77e-06 | 197 | 158 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 21-Trachea-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 7.23e-06 | 199 | 158 | 7 | 8eb8b086c38960200578a9fe8853ca6e894ddee4 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD4_TEM|ICU-NoSEP / Disease, Lineage and Cell Type | 2.16e-05 | 158 | 158 | 6 | 8616b308d5c1a1042b23a9aaca971029ba732eb8 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 162 | 158 | 6 | 4b9f80f701dcbb2508f497095cb8a7a2ca51cb5e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.04e-05 | 168 | 158 | 6 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.25e-05 | 170 | 158 | 6 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-05 | 171 | 158 | 6 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-05 | 175 | 158 | 6 | 26bd957498e41a3f1ffa60d3effa27ca8c4ba631 | |
| ToppCell | (03)_Secretory-(4)_1wkpi|(03)_Secretory / shred by cell type and Timepoint | 3.83e-05 | 175 | 158 | 6 | 06b52f85baa31b55bb31477244892b6da79fe2c9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.34e-05 | 179 | 158 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 185 | 158 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 5.21e-05 | 185 | 158 | 6 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.37e-05 | 186 | 158 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 6.04e-05 | 190 | 158 | 6 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.04e-05 | 190 | 158 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 158 | 6 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | PND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.40e-05 | 192 | 158 | 6 | 8171a60df481195c39a7f740effcae8e4deb6ca7 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.59e-05 | 193 | 158 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.59e-05 | 193 | 158 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 193 | 158 | 6 | 4aee372ba2c0351b0221d0d468707d1ad21526d6 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 6.59e-05 | 193 | 158 | 6 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 193 | 158 | 6 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 193 | 158 | 6 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 193 | 158 | 6 | aaa5042388dc451bff384c6bb237348f08280a08 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | 2224c7c943cfd5c1a329dfcf19d6e5ef8c49d85d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.78e-05 | 194 | 158 | 6 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.98e-05 | 195 | 158 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-05 | 196 | 158 | 6 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.18e-05 | 196 | 158 | 6 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-05 | 196 | 158 | 6 | 54c30023d04e7265373647f56fc93885804938b0 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.38e-05 | 197 | 158 | 6 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 7.38e-05 | 197 | 158 | 6 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.38e-05 | 197 | 158 | 6 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-05 | 198 | 158 | 6 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | 21-Trachea-Epithelial-Basal_cell|Trachea / Age, Tissue, Lineage and Cell class | 7.59e-05 | 198 | 158 | 6 | 6ed75b53030028be915a90c0bca4d12e471914a5 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.80e-05 | 199 | 158 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.80e-05 | 199 | 158 | 6 | 4099df3c052a9536d72ba01492317be7d83a79ad | |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | 7.80e-05 | 199 | 158 | 6 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 | |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | 7.80e-05 | 199 | 158 | 6 | d6c299312c747fb1b7c53644c53efc03a5fffe85 | |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | 7.80e-05 | 199 | 158 | 6 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 | |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | 7.80e-05 | 199 | 158 | 6 | 33ac6d77099076df01299be429f4ba96f2f34cc1 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.80e-05 | 199 | 158 | 6 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 158 | 6 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 200 | 158 | 6 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.02e-05 | 200 | 158 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 200 | 158 | 6 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-04 | 137 | 158 | 5 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.57e-07 | 166 | 150 | 10 | 2525_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; HL60; HG-U133A | 6.84e-06 | 198 | 150 | 9 | 1588_UP | |
| Drug | Biotin [58-85-5]; Down 200; 16.4uM; HL60; HT_HG-U133A | 6.84e-06 | 198 | 150 | 9 | 2428_DN | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.54e-05 | 167 | 150 | 8 | 6047_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A | 1.68e-05 | 169 | 150 | 8 | 2193_UP | |
| Drug | 1,4-bis-(phenoxyacetyl)piperazine | 1.90e-05 | 225 | 150 | 9 | CID001008511 | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.89e-05 | 190 | 150 | 8 | 6825_UP | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 4.51e-05 | 194 | 150 | 8 | 2430_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 4.51e-05 | 194 | 150 | 8 | 3938_DN | |
| Drug | fullerene C60 | ESPN NCOA6 B4GALNT4 ZBTB38 ABL1 ZBTB20 MBOAT7 PIEZO1 NRG2 CCDC187 POU2F1 PFAS RUNX2 SRCAP NCOR1 GTPBP2 AP1B1 GYS2 PLD2 BCAM TAF12 MUC4 MUC7 MED13 | 4.53e-05 | 1498 | 150 | 24 | ctd:C069837 |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; PC3; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 5868_DN | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 7312_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; HL60; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 1338_UP | |
| Drug | MCC-555 | 4.96e-05 | 31 | 150 | 4 | CID000204109 | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; HL60; HG-U133A | 5.02e-05 | 197 | 150 | 8 | 1578_DN | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; PC3; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 6746_UP | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; HL60; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 2730_DN | |
| Drug | Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A | 5.21e-05 | 198 | 150 | 8 | 2754_UP | |
| Drug | Zidovudine, AZT [30516-87-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 5333_UP | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; HL60; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 1270_UP | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; HL60; HG-U133A | 5.39e-05 | 199 | 150 | 8 | 1964_UP | |
| Disease | visual epilepsy (biomarker_via_orthology) | 7.95e-06 | 90 | 154 | 6 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Myeloid Leukemia, Chronic | 1.53e-05 | 29 | 154 | 4 | C0023473 | |
| Disease | obesity (implicated_via_orthology) | 1.83e-05 | 215 | 154 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | HIV infection | 2.71e-05 | 2 | 154 | 2 | EFO_0000764 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 6.06e-05 | 15 | 154 | 3 | EFO_0004599, EFO_0007892 | |
| Disease | tetranectin measurement | 8.09e-05 | 3 | 154 | 2 | EFO_0020957 | |
| Disease | mean corpuscular hemoglobin concentration | SP1 PIEZO1 RTTN GON4L PFAS RUNX1 CREB1 DMXL1 UBE2R2 MACF1 UBE3C MED17 LRIF1 MED13 MYB IMPG2 | 2.27e-04 | 1105 | 154 | 16 | EFO_0004528 |
| Disease | Clear cell sarcoma of kidney | 4.00e-04 | 6 | 154 | 2 | C0334488 | |
| Disease | retinitis pigmentosa | 4.00e-04 | 6 | 154 | 2 | MONDO_0019200 | |
| Disease | Failure to Thrive | 4.00e-04 | 6 | 154 | 2 | C0015544 | |
| Disease | Cystic kidney | 4.00e-04 | 6 | 154 | 2 | C0022679 | |
| Disease | Headache, fasting blood glucose measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0004465, HP_0002315 | |
| Disease | progressive supranuclear palsy | 5.63e-04 | 31 | 154 | 3 | MONDO_0019037 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 6.37e-04 | 131 | 154 | 5 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 6.37e-04 | 131 | 154 | 5 | C4552091 | |
| Disease | Juvenile arthritis | 6.37e-04 | 131 | 154 | 5 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 6.37e-04 | 131 | 154 | 5 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 7.29e-04 | 135 | 154 | 5 | C0087031 | |
| Disease | Nonsyndromic Deafness | 8.69e-04 | 81 | 154 | 4 | C3711374 | |
| Disease | osteoarthritis, knee, body mass index | 1.28e-03 | 41 | 154 | 3 | EFO_0004340, EFO_0004616 | |
| Disease | Cystic Kidney Diseases | 1.44e-03 | 11 | 154 | 2 | C1691228 | |
| Disease | Prostatic Neoplasms | 1.53e-03 | 616 | 154 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.53e-03 | 616 | 154 | 10 | C0376358 | |
| Disease | C-reactive protein measurement | NCOA6 SP3 DCHS2 ZBTB9 NCOR1 ZNF106 GYS2 PKD1 MACF1 TAF4 PLD2 BCAM NFAT5 GCN1 TMEM18 | 1.67e-03 | 1206 | 154 | 15 | EFO_0004458 |
| Disease | hemoglobin A1 measurement | 1.70e-03 | 520 | 154 | 9 | EFO_0007629 | |
| Disease | response to diuretic, high density lipoprotein cholesterol measurement | 1.73e-03 | 12 | 154 | 2 | EFO_0004612, GO_0036270 | |
| Disease | Carcinogenesis | 2.03e-03 | 13 | 154 | 2 | C0596263 | |
| Disease | Arthritis, Psoriatic | 2.36e-03 | 14 | 154 | 2 | C0003872 | |
| Disease | eosinophil measurement | 2.51e-03 | 108 | 154 | 4 | EFO_0803540 | |
| Disease | body weight | MGAM ZBTB38 RTTN GON4L MDGA2 RABGAP1 AP3B1 MEX3C SLC38A2 NCOR1 EYS USF3 EGR1 PKD1 TMEM18 | 2.55e-03 | 1261 | 154 | 15 | EFO_0004338 |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.72e-03 | 15 | 154 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | endometriosis (biomarker_via_orthology) | 3.10e-03 | 16 | 154 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | colorectal mucinous adenocarcinoma | 3.10e-03 | 16 | 154 | 2 | EFO_0009361 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.10e-03 | 16 | 154 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | SP3 LMTK2 GON4L ZNF804A NPTN EYS POM121 GYS2 PKD1 TAF4 GCN1 MED13 | 3.14e-03 | 914 | 154 | 12 | EFO_0004532 |
| Disease | facial morphology measurement | 3.20e-03 | 466 | 154 | 8 | EFO_0007841 | |
| Disease | mean reticulocyte volume | SP1 SP3 ABCB7 PIEZO1 RTTN RUNX1 CPED1 PTPRA TMEM131L TAF4 MYB | 3.25e-03 | 799 | 154 | 11 | EFO_0010701 |
| Disease | phosphatidylcholine 40:6 measurement | 3.50e-03 | 17 | 154 | 2 | EFO_0010389 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.50e-03 | 17 | 154 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | pulmonary surfactant-associated protein d measurement | 3.92e-03 | 18 | 154 | 2 | EFO_0020693 | |
| Disease | loneliness measurement | 4.12e-03 | 124 | 154 | 4 | EFO_0007865 | |
| Disease | HETE measurement | 4.21e-03 | 62 | 154 | 3 | EFO_0801166 | |
| Disease | puberty onset measurement | 4.24e-03 | 125 | 154 | 4 | EFO_0005677 | |
| Disease | hydrocephalus (implicated_via_orthology) | 4.37e-03 | 19 | 154 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | hair colour measurement | 5.14e-03 | 615 | 154 | 9 | EFO_0007822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSVSPLILSSNLPV | 146 | Q9BVC5 | |
| LPSSLSVFQNPTDVA | 131 | P15056 | |
| LLPSPSVITTQSENI | 2561 | A6H8Y1 | |
| TPSLASFDQPATIQT | 356 | A0A096LP49 | |
| QFQLLFPSTTPGIQS | 466 | A4D0V7 | |
| LTQPAVALPTSLSLS | 106 | Q8IX12 | |
| LQPSTSLLPTLNRTF | 111 | Q9H5V8 | |
| QPLTPNQIVSTLFTS | 331 | Q92685 | |
| QFAQSPNVTPIFTLS | 361 | Q9BX10 | |
| AIFSTQRQSLPPVTT | 431 | P54840 | |
| FPENQPVSSLVTTIT | 2576 | Q6V0I7 | |
| SPNQTVEISLPLSTV | 786 | Q10567 | |
| TFTTLLQNIPSFAPV | 876 | Q6PL18 | |
| QTPSPLQELSAQSSV | 421 | Q86WK7 | |
| TFPPATALALVSTIQ | 171 | Q9BZG8 | |
| CPSLLPTQQSASLVS | 481 | P52569 | |
| QLSRPLSQAVSFSTP | 396 | Q9P1Y5 | |
| SSPLSEQTSVPLLFA | 2171 | Q9Y485 | |
| LITLSTVFNLPSPLN | 746 | O75185 | |
| TSAVIIAAPQNFTPS | 1006 | O00203 | |
| VTSCFSQPLPVSISN | 1136 | Q9HBD1 | |
| SLAQSPLKLFPSQAT | 201 | P22736 | |
| LDQVLTSPFNTTFPL | 2166 | Q01484 | |
| QLLSPSSSIVPAFNT | 761 | O43747 | |
| LSNQLSASSTINPVP | 96 | Q9Y3P9 | |
| LTFSSPVTNQAIAIP | 1766 | Q8TEM1 | |
| VLVTTLPSSVAFTPQ | 4751 | Q8WXI7 | |
| FTTALISNATPLPVT | 966 | Q99102 | |
| VSQPTFINSVLPISA | 21 | Q9Y215 | |
| TFPQILAPIIFSTSI | 411 | Q14667 | |
| ILVFPTSSTIQVAPA | 1996 | Q71F56 | |
| SPLQIPVSRSFSSTL | 196 | O60732 | |
| PVSPSSSSTLLSLFQ | 236 | O60732 | |
| LTPIFQRTDPISTQT | 1246 | Q5T1H1 | |
| FTEVQLSSVNPPSLS | 231 | Q9H8Y8 | |
| SSSTSASVQLPIFQP | 86 | Q5T3J3 | |
| ASTNATPVPITTTLF | 2011 | Q2M2H8 | |
| PNVTTLAPISNVTSA | 31 | Q04900 | |
| LAPISNVTSAPVTSL | 36 | Q04900 | |
| IVSPQFQEISLPTTS | 411 | Q8IZA0 | |
| FPTQQPNTTTLASRK | 821 | O43451 | |
| LSPVSFSPVLAQSLE | 336 | O60291 | |
| STQLPNTAFNKTITP | 1161 | Q5HYC2 | |
| PQLQAFLVPKSTTSS | 1316 | Q5HYC2 | |
| VSVQPLNFDLSSPTS | 361 | B1AK53 | |
| TQQPSLTPLSTIKAF | 281 | P18146 | |
| VRSNFSLLTNVPVPS | 191 | P27815 | |
| PTLTLPQSLQSAFSG | 21 | A6NMT0 | |
| LATQVPTFEITSPNS | 611 | O14511 | |
| SLNIASPPSLILNTV | 2591 | O94854 | |
| TPTPFTNAVQLLLTL | 96 | Q96N66 | |
| QPSNQTTLPATLSIA | 161 | Q9UQV4 | |
| SPAEVFTLSVPNISL | 101 | Q8IWU2 | |
| TPPVNTRVLAFLSSV | 2086 | Q92616 | |
| FTQTSPVADAPNILT | 556 | P10242 | |
| IISQPFPSLQLSISL | 331 | Q9NVC6 | |
| GSQVFLQPLSSTPVS | 386 | Q96N21 | |
| PATSAIPFISENISQ | 591 | P23471 | |
| TSSVPLVLDSFLTPQ | 76 | Q9NQN1 | |
| SPANLSASVATVQLP | 126 | P24158 | |
| TLTLQTPSSPILCTQ | 426 | O94916 | |
| TNVLSSTFLSPQCSP | 621 | Q8IZQ8 | |
| IDVNISSSTVPPNLT | 431 | Q7Z553 | |
| NIASPPSLILNTVLS | 6466 | Q9UPN3 | |
| LLQSQPSITLTSQPA | 236 | P14859 | |
| FLSPESPTNQTTVIV | 2046 | Q6V1P9 | |
| TLTFSNTSTPTFNIP | 521 | A6NF01 | |
| SSISTPLPPNQITVF | 1586 | Q14686 | |
| PTLTFSNTSTPTFNI | 936 | Q96HA1 | |
| LPNVTFLPQNATTIS | 126 | Q8TAX7 | |
| QLSVVDFLPTTAQPT | 131 | A6NJW9 | |
| IISTQTAIPATTPTF | 1311 | Q6WRI0 | |
| APQSQFLIPTSLSVS | 396 | Q6AI39 | |
| SNLPVNTSISSVQLP | 196 | Q7Z3S7 | |
| QLSVVDFLPTTAQPT | 131 | P10966 | |
| TRSLNLTFATPLQPQ | 186 | Q96BT3 | |
| AQSSPANFRITSPTV | 461 | Q6K0P9 | |
| QTIPITTLLVNPTSF | 1176 | Q3T8J9 | |
| QPSSTAFIPLISTRV | 996 | P00519 | |
| SPIQIFTIQTRTPFS | 626 | Q9UQ52 | |
| ATSSAPTVTLVQLPN | 46 | P16220 | |
| LPAFPTSSLLTQSQK | 2106 | Q99698 | |
| QSFTPQCSLIRSLTP | 471 | Q13495 | |
| TVSSFLPQAPSRQIS | 46 | O43248 | |
| TAVNSTTQISPIPAL | 1106 | Q9P267 | |
| ITIIDSPSFIVSPLN | 301 | Q9BVP2 | |
| TSPSVLLNLQCPTTQ | 101 | Q8NCS7 | |
| SPINIISSQAVYSPS | 31 | P43166 | |
| PSVVSLTPTTFNELV | 556 | Q8IXB1 | |
| PINPTLNTTYSFLTT | 321 | P07686 | |
| ASLPTVPVLSRTQNF | 426 | P50895 | |
| TVPAVLSPNATLALT | 1026 | P98161 | |
| LTSLSVAPTFSPNIT | 56 | P18433 | |
| SPNITLGPTYLTTVN | 66 | P18433 | |
| PQETQSAFSIPVSTL | 546 | Q9GZY0 | |
| APQVLSSTSLPTNFS | 306 | Q5HYA8 | |
| LVLSTFPSTPLVTEQ | 176 | A6NNL0 | |
| LVLSTFPSTPLVTEQ | 176 | B1AL46 | |
| FTLTITVFTNPPQVA | 146 | Q01196 | |
| SFTLTITVFTNPPQV | 196 | Q13950 | |
| LGSTEFQPLVQSTTL | 1556 | Q86VV8 | |
| FQPLVQSTTLLPEAS | 1561 | Q86VV8 | |
| ATVTSALQPPVLSLT | 711 | O00268 | |
| QFEPVLLPTSTTNFT | 331 | A2VDJ0 | |
| LPNTSESFQPVSTVL | 331 | Q86VY9 | |
| PSALINLSNFSSIKP | 6 | Q16514 | |
| LQASPSPLTTVSLQD | 531 | Q9H6K5 | |
| FQNSPSALVSTPVRT | 2081 | O75376 | |
| VSTPNLPQESLTSIL | 571 | Q8IWB4 | |
| LLLLSPPAATASQTQ | 141 | Q5U5Q3 | |
| LLPTPITQQASLTSL | 166 | Q96M27 | |
| APSLPQQLVIASQSS | 781 | Q15714 | |
| QQLPAVSSLPSASSI | 816 | Q15714 | |
| SSLLSQPNLVAPTSQ | 1471 | Q9UHV7 | |
| LSIDSLPSSSFTQPV | 526 | Q9BZV3 | |
| FPTQTLSLTPASSLV | 1711 | Q6ZRS2 | |
| ASSLVPTPAQTLSLA | 1721 | Q6ZRS2 | |
| LLPVNSVSAATLTPS | 266 | P08047 | |
| FSQPVQTTDSLPLTT | 401 | Q9NZP6 | |
| NTTPPSKTVILQSTF | 826 | Q9NZP6 | |
| TSPLTQLTLQASPLQ | 481 | Q969V6 | |
| PVTLFQPSVSSAAQV | 481 | O94993 | |
| SPLQITPQTATVAFD | 461 | O75027 | |
| TSFLSLSQVSGPQLP | 626 | Q76KP1 | |
| NVLVSQFTPESFPLT | 76 | O75443 | |
| QASSPPATFLNIQTT | 36 | Q96A04 | |
| VSTPNLPQESLTSIL | 571 | Q5VYP0 | |
| VTFSNTLPRANTPSV | 411 | Q7Z2D5 | |
| PLLNQSISPLSSSVL | 501 | Q86UP3 | |
| SVISLLNEPNTFSPA | 126 | P49427 | |
| SPTDPTSVQTLLFNL | 396 | Q9HC29 | |
| TFQPLTQRLSESPVF | 391 | O60673 | |
| VSTPNLPQESLTSIL | 571 | Q5TZJ5 | |
| ILTSQFPIPSLFATI | 636 | A0A1B0GUW6 | |
| VSTPNLPQESLTSIL | 571 | Q5VU36 | |
| RPPTVVSNTFTALIL | 536 | P04844 | |
| CLFSLLTQVTTEPPT | 11 | P05452 | |
| TINTTLTQPTALVPA | 256 | Q96QD8 | |
| TQSSIPFKSQASVIP | 31 | Q5TH74 | |
| FTSTPVSLSTGQLPN | 506 | Q02447 | |
| FTEPSQVLPFLTSSQ | 41 | A6NE52 | |
| GPRLNFSTPTSTNIV | 91 | O15067 | |
| QPSPVSNQSLLSESV | 86 | Q6FIF0 | |
| PSVQRSFTQVTLPSF | 86 | Q12772 | |
| NPALTALTTPIQTAA | 271 | Q12772 | |
| APILATNTIPSATTA | 381 | Q9H0E3 | |
| SNLSSALPFTTPANT | 1811 | Q92545 | |
| SPVLPVTLQCNLTSS | 161 | Q9Y639 | |
| LSQTPSSAVTPVLNE | 446 | Q68DE3 | |
| SQPPSITSLSVNNLI | 1231 | Q68DE3 | |
| LTQILEPSTVFPSAN | 1186 | Q2KHR2 | |
| FPISRPNLTFSTLTV | 81 | A0A5B7 | |
| TVSQPGLSTFTAQLP | 541 | Q9HC78 | |
| IRSSPFQTPVQSSAS | 171 | Q96C00 | |
| LNSSLFSSPVIPIRN | 201 | Q9UJW8 | |
| IISPQLSSASLLTPQ | 1311 | Q15643 | |
| TLPLTQYLLTTSSPT | 1556 | Q86YA3 | |
| PLLVTSNSDQFLTTP | 516 | Q6NXT6 | |
| SVISLLNEPNTFSPA | 126 | Q712K3 | |
| PNSTNLLPTEISQSL | 891 | Q92508 | |
| TVNTLTNSPAIPLET | 621 | Q8NAP3 | |
| VQSSSTPQSLPLLLF | 16 | Q6ZS46 | |
| FSLPQKSLPVSLTAN | 146 | Q14679 | |
| LLPKSTSTANQLPFT | 581 | O14939 | |
| PTGASLQITTSPTFQ | 1171 | Q9H2Y7 | |
| TPQSPFLNLNSTCLT | 486 | Q6YBV0 | |
| SVSSFPVSIPAVLTQ | 6 | Q96B42 | |
| TFTPQNPLLNSLSVL | 281 | Q5W0B7 | |
| QPTILLNTVSASASP | 931 | Q6EMB2 | |
| ITSNIVASNSLPPAT | 216 | Q9Y5A9 | |
| QTFLSQLPVSPASAS | 346 | Q15386 | |
| FLSQIPALTRTSLPQ | 1131 | Q7Z570 | |
| SVQKSSAFPPNLLTS | 146 | E9PAV3 |